The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
Key Takeaways and Learnings As advanced data analytics and AI take hold in healthcare, sponsors shouldn’t overlook the potential to predict who will e...
Key Takeaways and Learnings Community engagement is critical to improving health equity, but it has to start long before sponsors recruit patients for...
Key Takeaways and Learnings Nearly five years after its founding, Acclinate’s success shows there’s value in the company’s mission to improve diversit...
Key Takeaways and Learnings The recent FDA diversity in clinical trials guidance emphasizes how sponsors plan on reaching specific representation goal...
Key Takeaways and Learnings Though engaging communities of color for clinical trials can be challenging, improvement is entirely possible and evident ...
Key Takeaways and Learnings The clinical research sector continues to face challenges in running representative trials. Pharmacists’ unique roles with...
Key Takeaways and Learnings: Clinical research recruiters face increasing pressure to improve their strategies to make trials more inclusive. Building...
Key Takeaways and Learnings Recent clinical research recommendations reinforce the need for robust and sustained community engagement. The FDA’s recen...
Key Takeaways and Learnings Clinical trials fall short when communities of color are underrepresented. Trust and awareness are longstanding obstacles ...
